<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04969952</url>
  </required_header>
  <id_info>
    <org_study_id>201912238RINA</org_study_id>
    <nct_id>NCT04969952</nct_id>
  </id_info>
  <brief_title>Evaluation of an Interventional Module to Assist Physicians Introducing ACP to Cancer Patients</brief_title>
  <official_title>National Taiwan University Hospital,Taiwan (R.O.C)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of an Interventional module to assist physicians introducing ACP to cancer&#xD;
      patients&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigators hypothesize that compared to ACP brochure alone, educational module plus ACP&#xD;
      brochure is effective in assisting the physicians to introduce ACP to the patients and&#xD;
      completion of AD documentation&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 9, 2021</start_date>
  <completion_date type="Anticipated">July 2023</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Shared decision making (SDM) process through Advance Care Planning (ACP) consultation with cancer patients</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>Only investigator know</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Sign DNR (Do-Not-Resuscitate)</measure>
    <time_frame>3 month</time_frame>
    <description>After intervention cancer patients willing sing DNR</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Completion AD(Advance directive) documentation</measure>
    <time_frame>3 month</time_frame>
    <description>After intervention cancer patients completion of a new AD documentation</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Explain and predict health behaviors(Sign DNR / Completion AD)</measure>
    <time_frame>3 month</time_frame>
    <description>To evaluate factors that might hinder patient willingness to sign DNR / complete AD documentation by applying the The Transtheoretical Model (TTM).</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Cancer Patients</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group A had watching educational module plus ACP brochure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group B ACP brochure only</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>For interventional module</intervention_name>
    <description>Using vedio to assist physicians introducing advance care planning to cancer patients</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        &quot;Inclusion Criteria&quot; and &quot;Exclusion Criteria&quot;&#xD;
&#xD;
        Inclusion Criteria&#xD;
&#xD;
          1. Older than 20-years-old&#xD;
&#xD;
          2. Diagnosed with cancer&#xD;
&#xD;
          3. Have not signed any form of AD or DNR&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          1. Under 20-years-old&#xD;
&#xD;
          2. Can not speak or listen, difficult communication&#xD;
&#xD;
          3. Signed AD or DNR&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shao-Yi Cheng Shao-Yi, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shao-Yi Cheng</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shao-Yi Cheng Shao-Yi</last_name>
    <phone>02-23123456</phone>
    <phone_ext>66823</phone_ext>
    <email>scheng2140@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei county</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <contact>
      <last_name>Shao-Yi Cheng, PHD</last_name>
      <phone>02-23123456</phone>
      <phone_ext>66823</phone_ext>
      <email>scheng2140@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 29, 2021</study_first_submitted>
  <study_first_submitted_qc>July 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2021</study_first_posted>
  <last_update_submitted>July 20, 2021</last_update_submitted>
  <last_update_submitted_qc>July 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ACP brochure</keyword>
  <keyword>Interventional Module</keyword>
  <keyword>Advance directive</keyword>
  <keyword>cancer patients</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

